Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-041556
Filing Date
2018-07-05
Accepted
2018-07-05 16:09:48
Documents
1
Period of Report
2018-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4258
  Complete submission text file 0001209191-18-041556.txt   5605
Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 617-418-2200
Foundation Medicine, Inc. (Issuer) CIK: 0001488613 (see all company filings)

EIN.: 271316416 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O FOUNDATION MEDICINE, INC. 150 SECOND STREET CAMBRIDGE MA 02141
Business Address
Nallicheri Melanie (Reporting) CIK: 0001710655 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36086 | Film No.: 18940677